Urothelial cancer
1 – 10 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The association between animal protein, plant protein, and their substitution with bladder cancer risk : a pooled analysis of 10 cohort studies
(
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
2025) In European Urology Focus(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
(
- Contribution to journal › Article
- 2024
-
Mark
Urorektal fistulering efter rektalbiopsier vid strålproktopati
(
- Contribution to journal › Article
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization
(
- Contribution to journal › Article
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
(
- Contribution to journal › Article
-
Mark
Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy
(
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article